Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
CMPX holding history
Compass Therapeutics, Inc. in every 13F filed by Caxton Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CMPX overviewAll 13F holders of CMPXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −29,495−100.0% | Sold out | Holders |
| Q4 2025 | 29,495 | $158.4K | 3.7% | −24,008−44.9% | Reduced | Holders |
| Q3 2025 | 53,503 | $187.3K | 0.8% | +10,038+23.1% | Added | Holders |
| Q2 2025 | 43,465 | $113.0K | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 43,465 | $82.6K | 1.6% | 00.0% | Unchanged | Holders |
| Q4 2024 | 43,465 | $63.0K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 43,465 | $80.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 43,465 | $43.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 43,465 | $86.1K | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 43,465 | $67.8K | 0.4% | −43,308−49.9% | Reduced | Holders |
| Q3 2023 | 86,773 | $170.9K | 0.6% | +43,307+99.6% | Added | Holders |
| Q2 2023 | 43,466 | $138.2K | 0.4% | −168,274−79.5% | Reduced | Holders |
| Q1 2023 | 211,740 | $675.5K | 1.7% | +581+0.3% | Added | Holders |
| Q4 2022 | 211,159 | $1.06M | 2.7% | +211,159 | New | Holders |